TFE3 and nonpapillary renal cell carcinoma: Notably, patients with TFE3 rearrangement were significantly younger than those with ccRCC (median age, 49 vs. 58 years; p = 0.02) and demonstrated a markedly higher recurrence rate (50% vs. 18.8%; p = 0.04).